Gene · 54822
Papers2,329
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,329
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Boolean Seven-Layer Platelet Decision Model Models Consistently the Logic and Semiquantitatively the Dynamics of Platelet Activation and Inhibition. | Comput Struct Biotechnol J | 2026 | 42819776 | PubTator, text mining | PubMed |
| Mechanobiology of Osteoarthritis: Interactions Between Mechanical Stress, Inflammation, and Joint Remodeling. | Cell Biol Int | 2026 | 42808736 | PubTator, text mining | PubMed |
| Correction to: Chronic cadmium exposure promotes TRPM7‑dependent acquisition of a myofibroblast‑like phenotype in pancreatic stellate cells. | Cell Biol Toxicol | 2026 | 42773377 | PubTator, text mining | PubMed |
| Natural product-derived TRPM7 channel inhibitors in neurological injury: Mechanisms, pharmacological potential and translational challenges. | Br J Pharmacol | 2026 | 42760099 | PubTator, text mining | PubMed |
| Reciprocal Coupling among Extracellular Matrix Mechanics, Mechanosensitive Ion Channels, and Cell Remodeling Behaviors. | ACS Appl Mater Interfaces | 2026 | 42675897 | PubTator, text mining | PubMed |
| A tumor microenvironment-responsive calcium overload nanoplatform inducing PANoptosis for enhanced cancer immunotherapy. | Mater Today Bio | 2026 | 42576991 | PubTator, text mining | PubMed |
| Drugging non-canonical kinases in cancer therapeutics: Molecular targets, underlying mechanisms and small-molecule inhibitors. | Acta Pharm Sin B | 2026 | 42453394 | PubTator, text mining | PubMed |
| TRPM7 Channel-Mediated Mitochondrial Oxidative Stress Induces Dysfunction of Müller Cells Under High Glucose and Low Mg2+ Stress. | Front Biosci (Landmark Ed) | 2026 | 42411499 | PubTator, text mining | PubMed |
| TRPM7 in Peripheral and Central Immune Cells: Emerging Roles in Neuroinflammation and Neurological Disease. | Int J Mol Sci | 2026 | 42352884 | PubTator, text mining | PubMed |
| Biomarkers for assessing magnesium status. | Adv Clin Chem | 2026 | 42336500 | PubTator, text mining | PubMed |
| Integrative phosphoproteomic analysis identifies functional roles of TRPM7 phosphosites in oncogenesis. | Front Bioinform | 2026 | 42305666 | PubTator, text mining | PubMed |
| Exploring TRPM7 Channel-Kinase for Disease Modulation: A Translational Approach. | Curr Rev Clin Exp Pharmacol | 2026 | 42299001 | PubTator, text mining | PubMed |
| Pharmacophore Directed Retrosynthesis Applied to Waixenicin A: Synthesis and Bioactivity of Derivatives Bearing a Minimal Proposed Pharmacophore. | Org Lett | 2026 | 42276815 | PubTator, text mining | PubMed |
| Letter to the Editor: Rethinking TRPM7 as a Target in Colorectal Polyp Prevention. | J Nutr | 2026 | 42264598 | PubTator, text mining | PubMed |
| Conditional Immortalization of Human Cardiac Fibroblasts for Pro-Fibrotic and Anti-Fibrotic Drug Screening. | Front Biosci (Landmark Ed) | 2026 | 42216555 | PubTator, text mining | PubMed |
| TRPM7 kinase: a target for multimodal drug development in neurological disorders. | Acta Pharmacol Sin | 2026 | 42191897 | PubTator, text mining | PubMed |
| Immunotherapy and postoperative bone defect repair strategies based on osteosarcoma tumor microenvironment characteristics: balancing antitumor effects and promotion of bone regeneration. | Regen Biomater | 2026 | 42179886 | PubTator, text mining | PubMed |
| Pyroptosis in epilepsy: from pathophysiological mechanisms to therapeutic strategies. | Front Cell Dev Biol | 2026 | 42111266 | PubTator, text mining | PubMed |
| Intracellular TRPM7-Mediated Zn2+ Release: A Novel Pyroptotic Axis in Myocardial Ischemia-Reperfusion Injury. | Circulation | 2026 | 42008595 | PubTator, text mining | PubMed |
| Evolution in metazoans of the TRPM channel family involves multiple gains and losses of genes and domains. | Mol Biol Evol | 2026 | 41968578 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54822/papers